乳腺癌胃转移1例

Abstract
Figure/Table
References (24)
Related Citation (15)

Download: PDF (900 KB) HTML (1 KB)
Export: BibTeX | EndNote (RIS)

Abstract Breast cancer is one of the most common malignant tumors in women. Most early breast cancer do not have typical symptoms and signs. Cell or histopathology is used diagnose the disease after physical examination or screening and treated by comprehensive treatment methods such as surgery, chemoradiotherapy, targeting and endocrine therapy. The prognosis of breast cancer is affected by many factors, for example pathological type, stage of disease, molecular markers, and so on. Although early breast cancer has become one of the most effective solid tumors after comprehensive treatment, the survival time will be shortened rapidly once recurrence and metastasis occur. The common metastatic sites are bone, lymph node, soft tissue, lung, brain, liver, and so on. The gastric as the first site of metastasis is relatively rare and the clinical, imaging and endoscopic manifestations are lack of specificity, making it difficult to differentiate from primary gastric cancer. This paper reports a case of invasive lobular breast carcinoma with gastric metastasis and analyzes the clinical characteristics, diagnosis, treatment and prognosis of the disease combined with the literature, in order to improve the clinical understanding of gastric metastasis from breast cancer.

Key words： Breast cancer Gastric metastasis Diagnosis Case report

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	LYU Lingyan1 WANG Xiuhong2 WAN Donggui3

Cite this article:

LYU Lingyan1 WANG Xiuhong2 WAN Donggui3. One case of gastric metastasis from breast cancer[J]. 中国医药导报, 2019, 16(36): 157-159,164.

URL:

http://www.yiyaodaobao.com.cn/EN/ OR http://www.yiyaodaobao.com.cn/EN/Y2019/V16/I36/157

[1] 郑荣寿，孙可欣，张思维，等.2015年中国恶性肿瘤流行情况分析[J].中华肿瘤杂志，2019，41（1）：19-28.
[2] Xu L，Ling S，Yan N，et al. Metastatic gastric cancer from breast carcinoma：A report of 78 cases [J]. Oncol Lett，2017，14（4）：4069-4077.
[3] Bray F，Ferlay J，Soeriomataram I，et al. Global Cancer Statistics 2018：GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries [J]. CA Cancer J Clin，2018，68（6）：394-424.
[4] Balakrishnan B，Shaik S，Burman-Solovyeva I. An Unusual Clinical Presentation of Gastrointestinal Metastasis from Invasive Lobular Carcinoma of Breast [J]. J Investig Med High Impact Case Rep，2016，4（2）：232 4709 616 639 723.
[5] McLemore EC，Pockaj BA，Reynolds C，et al. Breast cancer：presentation and intervention in women with gastrointestinal metastasis and carcinomatosis [J]. Ann Surg Oncol，2005，12（11）：886-894.
[6] Arrangoiz R，Papavasiliou P，Dushkin H，et al. Case report and literature review：Metastatic lobular carcinoma of the breast an unusual presentation [J]. Int J Surg Case Rep，2011，2（8）：301-305.
[7] Benfiguig A，Anciaux ML，Eugène CI，et al. Gastric metastasis of breast cancer occurring after a cancer-free interval of 30 years [J]. Ann Gastroenterol Hepatol（Paris），1992，28（4）：175-177.
[8] Kim DH，Son SM，Choi YJ，et al. Gastric metastasis from invasive lobular breast cancer，mimicking primary gastric cancer：A case report [J]. Medicine（Baltimore），2018，97（13）：e0 258.
[9] 杨丽，时高峰，周涛，等，非直接侵犯性胃转移癌的多层螺旋CT特征：5例病例报告并文献复习[J].世界华人消化杂志，2015，23（28）：4606-4610.
[10] 高福平，邢一鸣，薛松，等，胃转移性乳腺癌临床病理观察[J].诊断病理学杂志，2018，25（4）：278-280.
[11] 王一同，张振华，卢雯平，等.中医体质学在乳腺癌防治中的应用价值[J].中国医药，2017，12（6）：901-904.
[12] 杜岚，杨敬春，常莹，等.标准乳腺MRI与腋窝超声鉴别乳腺癌有无转移及晚期腋窝淋巴结病变的差异[J].中国医药导报，2017，14（35）：168-171.
[13] 李登华.MRI相比CT在诊断乳腺癌方面的优势分析[J].中国现代医生，2017，55(27)：102-104，108，封3.
[14] Qu Q，Zong Y，Fei XC，et al. The importance of biopsy in clinically diagnosed metastatic lesions in patients with breast cancer [J]. World J Surg Oncol，2014，12（1）：93-99.
[15] Sato T，Muto I，Fushiki M，et al. Metastatic breast cancer from gastric and ovarian cancer，mimicking inflammatory breast cancer：report of two cases [J]. Breast Cancer，2008，15（4）：315-320.
[16] Ordóñez NG. Value of GATA3 immunostaining in tumor diagnosis：a review [J]. Adv Anat Pathol，2013，20（5）：352-360.
[17] Miettinen M，McCue PA，Sarlomo-Rikala M，et al. GATA3：a multispecific but potentially useful marker in surgical pathology：a systematic analysis of 2500 epithelial and nonepithelial tumors [J]. Am J Surg Pathol，2014， 38（1）：13-22.
[18] Asch-Kendrick R，Cimino-Mathews A. The role of GATA3 in breast carcinomas：a review [J]. Hum Pathol，2016，48（2）：37-47.
[19] Sangoi AR，Shrestha B，Yang G，et al. The novel marker GATA3 is significantly more sensitive than traditional markers mammaglobin and GCDFP15 for identifying breast Cancer in surgical and cytology specimens of metastatic and matched primary tumors [J]. Appl Immunohistochem Mol Morphol，2016，24（4）：229-237.
[20] Gown AM，Fulton RS，Kandalaft PL. Markers of metastatic carcinoma of breast origin [J]. Histopathology，2016，68（1）：86-95.
[21] Gadde R，Tamariz L，Hanna M，et al. Metastatic gastric cancer（MGC）patients：Can we improve survival by metastasectomy? A systematic review and meta-analysis [J]. J Surg Oncol，2015，112（1）：38-45.
[22] Kliiger J，Gorbaty M. Metastasis to the pancreas and stomach from a breast cancer primary：a case report [J]. J Community Hosp Intern Med Perspect，2017，7（4）：234-237.
[23] Jucá PCFC，Corrêa S，Vignal GM，et al. HNF4A expression as a potential diagnostic tool to discriminate primary gastric cancer from breast cancer metastasis in a Brazilian cohort [J]. Diagn Pathol，2017，12（1）：43-50.
[24] Woo J，Lee JH，Lee KE，et al. Gastric Metastasis as the First Presentation One Year Before Diagnosis of Primary Breast Cancer [J]. Am J Case Rep，2018，26（19）：354-359.